Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology.

ABSTRACT:

Background

No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly compare these two medications. Matching-adjusted indirect comparison (MAIC) is a recent methodology that utilizes individual patient data (IPD) from clinical trials for one treatment and published aggregate data from another treatment to estimate the relative efficacy of both, providing rapid, reliable comparative efficacy results.

Objective

The aim of this study was to compare the efficacy of GXR and ATX for the treatment of ADHD using MAIC.

Study design

A systematic literature

SUBMITTER: Sikirica V 

PROVIDER: S-EPMC3824845 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature